Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact
Login Book a demo
Orthocell Ltd logo — Orthocell (ASX:OCC) is a regenerative medicine company empow...

Orthocell Ltd

Orthocell (ASX:OCC) is a regenerative medicine company empowering the body to heal | Tag or follow us at $OCC

Founded 2006 Australia Australia 42 employees Post-IPO Equity Total: $1.80M Biotechnology, Health and Wellness

General Information

Company Name Orthocell Ltd
Founded Year 2006
Location Australia Australia
Employees 42
Industries Biotechnology, Health and Wellness
Funding Stage Post-IPO Equity
Social

BounceWatch is an independent company data service, not affiliated with Orthocell Ltd. To contact Orthocell Ltd, visit orthocell.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Orthocell Ltd compare?

A PDF of Orthocell Ltd and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Orthocell Ltd soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Orthocell Ltd

Orthocell is a regenerative medicine company with a focus on biotechnology based in Australia. Established in 2008, the company is dedicated to developing breakthrough products that harness the power of the human body to heal, aiming to restore mobility, function, and performance. Orthocell's product portfolio comprises two complementary platform products - a collagen medical device and autologous cell therapies. The CelGro™ platform of collagen medical devices is specifically designed to augment the surgical repair of bone, nerve, tendon, and cartilage. On the other hand, the company's cell therapies encompass autologous tendon therapy and autologous chondrocyte implantation (OrthoACI™), aiming to facilitate the regeneration of damaged tendon and cartilage tissue. Though specific details regarding the company's last investment remain undisclosed, it is clear that Orthocell presents an intriguing proposition within the regenerative medicine space. As a venture capital entity, monitoring the company's advancements and potential opportunities for collaboration could prove to be valuable in staying abreast of innovative developments within the biotechnology sphere. Keep an eye on Orthocell (ASX:OCC) for further insights and investment prospects.

Business keywords: Regenerative Medicine, Soft Tissue Repair, Stem Cell Therapy, Orthopaedics, Sports Science, Exercise Physiology, Bio-therapeutic Company, Collagen Medical Devices, Autologous Cell Therapies, Tendon Therapy, Chondrocyte Implantation, Healthcare Innovation, Tissue Regeneration, Medical Technology

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Post IPO Equity $1.80M -
11 Dec 2018

Latest News

View All
WA Medtech Startups Showcased On Global Stage At LSI Asia 2025 — Startupnews
WA Medtech Startups Showcased On Global Stage At LSI Asia 2025
Startupnews Jun 08, 2025

Orthocell Ltd Alternatives & Competitors

View All Alternatives
Orthocell Ltd vs
StemSight - Vision Unlimited
StemSight - Vision Unlimited Finland

Curing blindness with regenerative cell therapies.

Seed
16 employees
Biotechnology, Health Care
Orthocell Ltd vs
NOVADIP Biosciences S.A.
NOVADIP Biosciences S.A. Belgium

Novadip is transforming the lives of patients using its unique 3M³ tissue regeneration technology pl...

Series B
58 employees
Biotechnology, Health Care
Orthocell Ltd vs
ORTEQ Sports Medicine
ORTEQ Sports Medicine United Kingdom

We aim to reduce patient suffering from meniscus and articular cartilage injury or degeneration by c...

Venture round
9 employees
Biotechnology, Health Care
View all alternatives

FAQ About Orthocell Ltd

Orthocell (ASX:OCC) is a regenerative medicine company empowering the body to heal | Tag or follow us at $OCC
Orthocell Ltd was founded in 2006.
Orthocell Ltd is headquartered in Australia.
Orthocell Ltd operates in Biotechnology and Health and Wellness. Its work centres on Regenerative Medicine, Soft Tissue Repair, Stem Cell Therapy and Orthopaedics.
Orthocell Ltd has approximately 42 employees.
Orthocell Ltd has completed 1 funding round, raising a total of $1.80M. The latest funding stage is Post-IPO Equity.
Top alternatives and competitors to Orthocell Ltd include StemSight - Vision Unlimited, NOVADIP Biosciences S.A., ORTEQ Sports Medicine, InGeneron, 苏州吉美瑞生医学科技有限公司. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Orthocell Ltd and StemSight - Vision Unlimited are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Orthocell Ltd, https://bouncewatch.com/company/orthocell, updated 9 November 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes